Announced
Completed
Synopsis
Trilantic, the private equity firm focused on mid-market transactions, completed the investment in Smile Eyes Group, a player in the German ophthalmology market headquartered in Munich. Financial terms were not disclosed. "We are impressed by Smile Eyes’s attractive position in the German ophthalmology market. Dres. Wiltfang and Bechmann have built an impressive network of highly specialised ophthalmic experts and we are excited to partner with them and their team to support their expansion strategy centred around the Smile Eyes concept," Henrik Bodenstab, Trilantic Partner.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.